Neurodegenerative diseases

Fujirebio has driven the development of diagnostics for dementia and they are world leaders in reliable Alzheimer’s disease diagnostics.

The test menu consists of CE-marked ELISA-based tests for quantification of hTAU, β-amyloid and phosphoTAU in liquids.

For research analysis of the dementia markers there are a number of kits based on ELISA technology, LUMINEX technology or molecular diagnostics. Contact us for more information and read more at Fujirebio’s website


Catharina Axörn Gräns